Effects of atorvastatin on microcirculatory endothelial function in patients with systemic sclerosis - Atorvastatin in systemic sclerosis
Phase 1
- Conditions
- Systemic sclerosis (also termed 'scleroderma')
- Registration Number
- EUCTR2005-003775-21-GB
- Lead Sponsor
- Salford Royal Hospitals NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 36
Inclusion Criteria
1. A diagnosis of systemic sclerosis
2. Age > 18 and < 75 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
1. Age < 18 or > 75 years
2. Pregnancy or breast feeding
3. Other contraindications to statin therapy (hypersensitivity, active liver disease, unexplained persistent elevations of serum transaminases).
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method